Coleman Wombwell

Represented ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS(r)), in an offering of common stock and multiple tranches of warrants registered on Form S-1

Represented AVITA Medical, Inc. (NASDAQ: RCEL; ASX: AVH), a regenerative medical company developing treatments for skin restoration, in its entry into a US$90.0 million secured credit facility with OrbiMed, including the issuance of a registered common stock warrant, in October 2023

Represented AVITA Medical, Inc. (NASDAQ: RCEL; ASX: AVH), a regenerative medical company developing treatments for skin restoration, in its registered at-the-market offering program with TD Cowen as sales agent, launched in April 2023

Advised Abemarle Corporation (NYSE: ALB), a global specialty chemicals company, in its US$1.7 billion public offering of three tranches of senior notes in June 2022

Served as US counsel for MDxHealth SA (NASDAQ: MDXH), a commercial-stage precision diagnostics company, in its $45.0 million initial public offering of American Depositary Shares on the Nasdaq Capital Market

Represented Exact Sciences Corporation (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, in its February 2020 offering of US$1.0 billion aggregate principal amount of 0.3750% convertible senior notes due 2028 and concurrent repurchase of a portion of its existing 1.0% convertible senior notes due 2025

Represented Exact Sciences Corporation (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, in its October 2020 registered direct offering of US$869.2 million of common stock

Represented Tyler Technologies (NYSE: TYL), a provider of integrated software and technology services to the public sector, in its March 2021 Rule 144A offering of US$600.0 million principal amount of its 0.25% convertible senior notes due 2026

Represented NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetics testing services and global oncology contract research services, in its concurrent public underwritten offerings of US$200.0 million of its common stock and US$300.0 million principal amount of its 0.25% convertible senior notes due 2028

Represented NextDecade Corporation (NASDAQ: NEXT), a liquefied natural gas (LNG) development company developing an LNG terminal and carbon capture project in the Port of Brownsville, Texas, in its private placements of three series of convertible preferred stock for over US$135.0 million of proceeds

Represented NextDecade Corporation (NASDAQ: NEXT), a liquefied natural gas (LNG) development company developing an LNG terminal and carbon capture project in the Port of Brownsville, Texas, in a US$50.0 million investment by an Abu Dhabi-based sovereign investor through a private placement of common stock

Represented Akoustis Technologies, Inc. (NASDAQ: AKTS), an integrated device manufacturer of high-band RF filters for mobile and other wireless applications, in its US$100.0 million at-the-market equity offering program

Represented Cue Biopharma, Inc. (NASDAQ: CUE), an immunotherapy company developing a proprietary class of biologics for the treatment of cancer and autoimmune diseases, in its initial public offering of common stock and listing on the Nasdaq Capital Market

Represented ENDRA Life Sciences Inc. (NASDAQ: NDRA), a developer of thermo-acoustic technology for ultrasound systems, in its initial public offering of units consisting of common stock and warrants and listing on the Nasdaq Capital Market

Represented ATech (Parent) Resolution Corp. (f/k/a Akoustis Technologies, Inc. (NASDAQ: AKTS), an integrated device manufacturer of high-band RF filters for mobile and other wireless applications) in an asset sale under Section 363 of the U.S. Bankruptcy Code to Tune Holdings Corp., a subsidiary of SpaceX Exploration Technologies, a California-headquartered designer, manufacturer, and operator of advanced rockets and spacecrafts, for US$30.2 million.

Represented the Special Committee of the Board of Directors of ARC Document Solutions, Inc. (NASDAQ: ARC), in connection with the company’s take-private transaction with an investor group led by its chief executive officer for cash consideration of US$3.40 per share

Served as securities counsel for AeroVironment, Inc. (NASDAQ: AVAV), a global leader in intelligent, multi-domain robotic systems, in its September 2023 acquisition of Tomahawk Robotics, Inc., for consideration of cash and stock with an aggregate value of approximately US$120.0 million

Represented Akoustis Technologies, Inc. (NASDAQ: AKTS), an integrated device manufacturer of high-band RF filters for mobile and other wireless applications, in its January 2023 acquisition of Grinding & Dicing Services, Inc., a US-based provider of premium back-end semiconductor supply chain services, for US$20.0 million in consideration consisting of cash, stock, and a secured note

Advised NextDecade Corporation (NASDAQ: NEXT), a liquefied natural gas (LNG) development company developing a LNG terminal and carbon capture project in the Port of Brownsville, Texas, in its February 2020 sale of Rio Bravo Pipeline Company, LLC for US$25.0 million

Advised Motion & Flow Control Products, Inc., a distributor of fluid connectors and other industrial products, in its acquisition of a complementary business with locations throughout the Southwestern US

Advised private equity-backed regional retailer of automotive part in acquisition of the assets of a New England car battery retailer

Advised private equity-backed provider of products and services to the automated external defibrillator ("AED") marketplace in its acquisition of an online retailer of AED products and training

Assisted healthcare system based in Northeast Indiana in its affiliation with a community mental health center with several facilities in Fort Wayne and surrounding areas